A 9-Year Evaluation of Temporal Trends in Alosetron Postmarketing Safety Under the Risk Management Program

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x13491798
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications